[1]
“EVALUATION OF THROMBOCYTOPENIA, D-DIMER, INFLAMMATORY CRP, AND CBC MARKERS IN COVID-19 CASES, INCLUDING PATIENTS FROM IRAQ, USING A CASE-CONTROL METHODOLOGY ”, SJUOZ, vol. 12, no. 4, pp. 442–449, Oct. 2024, doi: 10.25271/sjuoz.2024.12.4.1333.